Leveraging untargeted metabolomics in combination with machine learning to uncover novel insights into bladder cancer
Abstract Background Untargeted metabolomics has emerged as a powerful approach to uncover metabolic dysregulation associated with cancer progression. When integrated with a machine learning strategy it facilitates the discovery of key metabolic pathways and predictive biomarkers with high diagnostic...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMC
2026-04-01
|
| Cyfres: | Cancer & Metabolism |
| Pynciau: | |
| Mynediad Ar-lein: | https://doi.org/10.1186/s40170-026-00427-4 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
